EUCTR2010-023740-32-NO进行中(未招募)不适用
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder - Bergen_Lith_Bipol
Haukeland University Hospital0 个研究点目标入组 800 人开始时间: 2011年3月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Inclusion Criteria:
- •1) Any phase of bipolar I disorder including, depressive, manic, hypomanic, mixed, or baseline/euthymic/not symptomatic,
- •2) Lithium naïve patients and inadequately past lithium treated patients will be required to have had at least one affective episode in the last 12 months meeting DSM-IV criteria.Current lithium treated patients (CLTPs) will be stable on lithium monotherapy and will be exempted from this criterion if they have had no mood episodes meeting DSM-IV criteria in the last 6 months,
- •3) Both outpatients and inpatients will be permitted to enroll into this study,
- •4) Able to give informed consent, in the judgment of the investigator;
- •5) Age greater than or equal to 18 years;
- •6) Women of child bearing potential agree to inform their doctor at the earliest possible time of their plans to conceive, and to use adequate contraception (e.g. oral contraceptives, intrauterine device, barrier methods, or total abstinence from intercourse), and to understand the risks of lithium to the fetus and infant. Depo Provera is acceptable if it is started 3 months prior to enrollment;
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion Criteria:
- •1) Unwilling or unable to comply with study requirements;
- •2) Renal impairment (serum creatinine >1.5 mg/dL);
- •3) Thyroid stimulating hormone (TSH) over >20% above the upper normal limit (participants maintained on thyroid medication must be euthyroid for at least 3 months before Visit 1;
- •4) Other contraindication to lithium,
- •5) Currently in crisis such that inpatient hospitalization or other crisis management should take priority;
- •6) Subjects with alcohol/drug dependence who meet criteria for physical dependence requiring acute detoxification
- •7) Pregnant or breastfeeding;
- •8) Women of child-bearing potential who aren’t able to agree to the requirements specified above;
- •9) Those who have participated in a clinical trial of an investigational drug within the past 1 month;
- •10) Inability to agree to comply with the visit schedule or study procedures;
- •11) History of lithium toxicity, not due to mismanagement or overdose that required treatment.
- •12) Current unstable medical condition.
研究者
相似试验
已完成
不适用
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)Bipolar Affective DisorderNCT01272531University of California, San Diego560
招募中
不适用
Assessment of the impact of psychobiotics supplementation on the occurrence of depression and anxiety disorders in people with a history of Covid-19 diseaseCOVID19F41.2Mixed anxiety and depressive disorderDRKS00026955Department of Pediatric Gastroenterology and Metabolic Diseases; Poznan University of Medical Sciences80
已完成
Unknown
Investigating the effect of modified psychobiotic diet on depressioIRCT20131125015536N14Tehran University of Medical Sciences44
尚未招募
不适用
Role of beta-blocker in Stroke outcome.CTRI/2022/07/043879Prinicipal Investigator
进行中(未招募)
不适用
How various medications affect the way we process informatioHealthy volunteersEUCTR2012-002476-14-FIJesper Ekelund
